Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study

Cancer. 1982 Mar 1;49(5):835-9. doi: 10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Menopause
  • Methotrexate / administration & dosage
  • Middle Aged
  • Prednisone / administration & dosage
  • Random Allocation
  • Vincristine / administration & dosage

Substances

  • Antineoplastic Agents
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Fluorouracil
  • Prednisone
  • Methotrexate